Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-18

Clinical Trial Update: Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating chemoembolization with irinotecan beads as a second-line treatment for unresectable metastatic colorectal cancer was terminated; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemoembolization
  • Irinotecan bead chemoembolization (irinotecan)

Snippet

Sponsor: Generic Devices Consulting, Inc. | Conditions: Unresectable Metastatic Colo-rectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-09-18